共 212 条
[11]
Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)
[J].
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY,
2023, 89 (03)
:478-485
[16]
Staphylococcus aureus: an underestimated factor in the pathogenesis of atopic dermatitis?
[J].
POSTEPY DERMATOLOGII I ALERGOLOGII,
2019, 36 (01)
:11-17
[17]
Eczematous Drug Eruptions
[J].
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY,
2021, 22 (03)
:349-366